Business

AstraZeneca to list ordinary shares directly on NYSE market

AstraZeneca, the Anglo-Swedish pharmaceutical company has announced plans to list its ordinary shares directly on the New York Stock Exchange. This move is aimed at attracting a wider and more diverse base of investors. The pharmaceutical company stated on Monday that this direct listing would replace its current American Depositary Receipts listing on the Nasdaq, […]